Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 73 publications
Developmental reversion underlies resistance to immune checkpoint blockade in kidney cancer.
Journal: bioRxiv : the preprint server for biology
Published: August 20, 2026
Complete response to dual immune checkpoint blockade in a patient with Birt-Hogg-Dubé syndrome and epithelioid angiomyolipoma.
Journal: Journal for immunotherapy of cancer
Published: July 17, 2026
Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 14, 2026
Anatomical dynamics define cancer cachexia subtypes and identify systemic inflammation as a marker of lethal wasting.
Journal: medRxiv : the preprint server for health sciences
Published: May 18, 2026
Cancer type-specific variation in patterns of driver alterations across 50,000 tumors.
Journal: Cancer cell
Published: April 19, 2026
Expanding the phenotype of hereditary renal cell carcinoma syndromes: Implications for surveillance and management.
Journal: Journal of the National Cancer Institute
Published: April 13, 2026
From diversity to function: microbiome precision in RCC.
Journal: Nature reviews. Urology
Published: April 08, 2026
Palliative Care and EOL Care Utilization in Hospitalized Adults of Dharmic Religions with Cancer.
Journal: Journal of pain and symptom management
Published: April 06, 2026
Sensitive CAR T cells redefine targetable CD70 expression in solid tumors.
Journal: Science (New York, N.Y.)
Published: February 26, 2026
Panitumumab-Based EGFR Blockade in SMARCB1-Deficient Renal Medullary Carcinoma: Preclinical Basis and Prospective Clinical Activity.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 27, 2026
Pathologic Response to Immunotherapy Is Associated with Survival in Patients Undergoing Delayed Nephrectomy for Metastatic Renal Cell Carcinoma.
Journal: European urology oncology
Published: June 05, 2025
Last Updated: 09/26/2026